Helse Forde   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Norway (2002)

Organization Overview

First Clinical Trial
2019
NCT04121403
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Førde Central Hospital | Helse Forde

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 3)

Sclerosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 9